<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report" dtd-version="1.3">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">HGG Adv</journal-id>
      <journal-id journal-id-type="iso-abbrev">HGG Adv</journal-id>
      <journal-title-group>
        <journal-title>Human Genetics and Genomics Advances</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2666-2477</issn>
      <publisher>
        <publisher-name>Elsevier</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">35047857</article-id>
      <article-id pub-id-type="pmc">8756495</article-id>
      <article-id pub-id-type="pii">S2666-2477(21)00053-1</article-id>
      <article-id pub-id-type="doi">10.1016/j.xhgg.2021.100072</article-id>
      <article-id pub-id-type="publisher-id">100072</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A recurrent, <italic>de novo</italic> pathogenic variant in <italic>ARPC4</italic> disrupts actin filament formation and causes microcephaly and speech delay</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="au1">
          <name>
            <surname>Laboy Cintron</surname>
            <given-names>Dianne</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="fn2" ref-type="fn">14</xref>
        </contrib>
        <contrib contrib-type="author" id="au2">
          <name>
            <surname>Muir</surname>
            <given-names>Alison M.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="fn2" ref-type="fn">14</xref>
        </contrib>
        <contrib contrib-type="author" id="au3">
          <name>
            <surname>Scott</surname>
            <given-names>Abbey</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author" id="au4">
          <name>
            <surname>McDonald</surname>
            <given-names>Marie</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author" id="au5">
          <name>
            <surname>Monaghan</surname>
            <given-names>Kristin G.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author" id="au6">
          <name>
            <surname>Santiago-Sim</surname>
            <given-names>Teresa</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author" id="au7">
          <name>
            <surname>Wentzensen</surname>
            <given-names>Ingrid M.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author" id="au8">
          <name>
            <surname>De Luca</surname>
            <given-names>Chiara</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <collab>Italian Undiagnosed Diseases Network</collab>
        </contrib>
        <contrib contrib-type="author" id="au9">
          <name>
            <surname>Brancati</surname>
            <given-names>Francesco</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
          <xref rid="aff6" ref-type="aff">6</xref>
        </contrib>
        <contrib contrib-type="author" id="au10">
          <name>
            <surname>Harris</surname>
            <given-names>David J.</given-names>
          </name>
          <xref rid="aff7" ref-type="aff">7</xref>
        </contrib>
        <contrib contrib-type="author" id="au11">
          <name>
            <surname>Goueli</surname>
            <given-names>Cecilia</given-names>
          </name>
          <xref rid="aff8" ref-type="aff">8</xref>
        </contrib>
        <contrib contrib-type="author" id="au12">
          <name>
            <surname>Stottmann</surname>
            <given-names>Rolf</given-names>
          </name>
          <xref rid="aff9" ref-type="aff">9</xref>
        </contrib>
        <contrib contrib-type="author" id="au13">
          <name>
            <surname>Prada</surname>
            <given-names>Carlos E.</given-names>
          </name>
          <xref rid="aff8" ref-type="aff">8</xref>
          <xref rid="aff10" ref-type="aff">10</xref>
          <xref rid="aff11" ref-type="aff">11</xref>
        </contrib>
        <contrib contrib-type="author" id="au14">
          <name>
            <surname>Biderman Waberski</surname>
            <given-names>Marta</given-names>
          </name>
          <xref rid="aff12" ref-type="aff">12</xref>
        </contrib>
        <contrib contrib-type="author" id="au15">
          <name>
            <surname>Mefford</surname>
            <given-names>Heather C.</given-names>
          </name>
          <email>heather.mefford@stjude.org</email>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="fn1" ref-type="fn">13</xref>
          <xref rid="cor1" ref-type="corresp">&#x2217;</xref>
        </contrib>
        <aff id="aff1"><label>1</label>Department of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA, USA</aff>
        <aff id="aff2"><label>2</label>Division of Genetic Medicine, Seattle Children&#x2019;s Hospital, Seattle, WA, USA</aff>
        <aff id="aff3"><label>3</label>Department of Pediatrics, Duke University, Durham, NC, USA</aff>
        <aff id="aff4"><label>4</label>GeneDx, Inc, 207 Perry Parkway, Gaithersburg, MD, USA</aff>
        <aff id="aff5"><label>5</label>Department of Life, Health and Environmental Sciences, University of L&#x2019;Aquila, 67100 L&#x2019;Aquila, Italy</aff>
        <aff id="aff6"><label>6</label>IRCCS San Raffaele Roma, 00163 Roma, Italy</aff>
        <aff id="aff7"><label>7</label>Division of Genetics and Genomics, Boston Children&#x2019;s Hospital, Harvard Medical School, Boston, MA, USA</aff>
        <aff id="aff8"><label>8</label>Department of Pediatrics, Cincinnati Children&#x2019;s Hospital, Cincinnati, OH, USA</aff>
        <aff id="aff9"><label>9</label>Nationwide Children&#x2019;s Hospital, Columbus, OH, USA</aff>
        <aff id="aff10"><label>10</label>Division of Genetics, Birth Defects and Metabolism, Ann &amp; Robert H. Lurie Children&#x2019;s Hospital of Chicago, Chicago, IL 60611, USA</aff>
        <aff id="aff11"><label>11</label>Department of Pediatrics, Feinberg School of Medicine of Northwestern University, Chicago, IL 60611, USA</aff>
        <aff id="aff12"><label>12</label>Department of Pediatrics, Virginia Commonwealth University, Fairfax, VA, USA</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>&#x2217;</label>Corresponding author <email>heather.mefford@stjude.org</email></corresp>
        <fn id="fn1">
          <label>13</label>
          <p id="ntpara0010">Present address: Center for Pediatric Neurological Disease Research, St. Jude Children&#x2019;s Research Hospital, Memphis, TN, USA</p>
        </fn>
        <fn id="fn2">
          <label>14</label>
          <p id="ntpara0015">These authors contributed equally</p>
        </fn>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>25</day>
        <month>11</month>
        <year>2021</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
      <pub-date pub-type="collection">
        <day>13</day>
        <month>1</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>25</day>
        <month>11</month>
        <year>2021</year>
      </pub-date>
      <volume>3</volume>
      <issue>1</issue>
      <elocation-id>100072</elocation-id>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>7</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>11</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2021 The Authors</copyright-statement>
        <copyright-year>2021</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
          <license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
        </license>
      </permissions>
      <abstract id="abs0010">
        <title>Summary</title>
        <p>We report seven affected individuals from six families with a recurrent, <italic>de novo</italic> variant in the <italic>ARPC4</italic> gene (c.472C&gt;T [p.Arg158Cys (GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_005718.4" id="intref0010">NM_005718.4</ext-link>)]). Core features in affected individuals include microcephaly, mild motor delays, and significant speech impairment. ARPC4 is a core subunit of the actin-related protein (ARP2/3) complex, which catalyzes the formation of F-actin networks. We show that the recurrent ARPC4 missense change is associated with a decreased amount of F-actin in cells from two affected individuals. Taken together, our results implicate heterozygous <italic>ARPC4</italic> missense variants as a cause of neurodevelopmental disorders and microcephaly.</p>
      </abstract>
      <abstract abstract-type="teaser" id="abs0015">
        <p>We report a neurodevelopmental disorder with microcephaly in seven affected individuals with the same <italic>de novo</italic> variant in the <italic>ARPC4</italic> gene. The recurrent variant in ARPC4, a subunit of the complex that catalyzes F-actin network formation, is associated with decreased F-actin in cells from affected individuals.</p>
      </abstract>
      <kwd-group id="kwrds0010">
        <title>Keywords</title>
        <kwd>actin</kwd>
        <kwd>microcephaly</kwd>
        <kwd>ARPC4</kwd>
        <kwd>developmental delay</kwd>
        <kwd>
          <italic>de novo</italic>
        </kwd>
        <kwd>genetic</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1">
      <title>Main text</title>
      <p id="p0010">The actin cytoskeleton plays an important role in many developmental processes in the brain, including cell division and proliferation, cell and axon migration, and synaptic plasticity. Disruption of actin dynamics (polymerization and depolymerization) can lead to abnormal brain development, including periventricular heterotopia<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> and microcephaly.<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> The actin cytoskeleton is composed of highly branched networks of actin filaments (F-actin), which are assembled from free actin monomers (G-actin). The nucleation of new F-actin filaments is the rate-limiting step of F-actin polymerization.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> The actin-related protein-2/3 (ARP2/3) complex is a highly conserved actin-nucleating complex that binds to the side of existing actin filaments and nucleates the formation of new daughter filaments to form branched actin networks.<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref> As the only nucleator of branched actin filaments, it has a central role in both F-actin polymerization and actin cytoskeleton organization.</p>
      <p id="p0015">The ARP2/3 complex consists of seven subunits: two actin-related proteins (ARP2 and ARP3) and five ARP2/3 complex polypeptides (ARPC1B and ARPC2-5). ARPC4 is essential for the structural integrity of the ARP2/3 complex function. It binds to ARPC2, forming the structural core of the complex around which the other subunits bind.<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> Consistent with its central role in actin cytoskeleton formation, knockout of <italic>Arpc4</italic> in mice is embryonic lethal. Conditional knockout of <italic>Arpc4</italic> in the epidermis of mice leads to a reduction of F-actin levels and morphological changes in keratinocytes, including the absence of lamellipodia and ruffles, congruent with the disruption of the actin cytoskeleton.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref></p>
      <p id="p0020">Through clinical exome sequencing, we identified a <italic>de novo</italic> variant of uncertain significance in the <italic>ARPC4</italic>&#xA0;gene (hg19: chr3: g.9845668C&gt;T [c.472C&gt;T; p.Arg158Cys (GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_005718.4" id="intref0015">NM_005718.4</ext-link>)]) in a young girl (individual 1a) with primary microcephaly, mild motor delays, and significant speech delay. Her younger brother (individual 1b) presented similarly, with mild microcephaly and motor delays; targeted testing confirmed that he had the same <italic>de novo</italic> variant, suggesting gonadal mosaicism in a parent. Using targeted deep sequencing,<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> we confirmed low-level mosaicism (0.7% variant allele frequency) in their mother. Using GeneMatcher,<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref> we identified five additional individuals with the same <italic>de novo</italic> variant. The variant is absent from control populations (gnomADv2.1.1). <italic>In silico</italic> analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect. The Institutional Review Board of the University of Washington approved this study. Parents of affected children included in this study provided informed consent.</p>
      <p id="p0025">All seven affected individuals with the recurrent variant presented with motor delays noted by 1 year (<xref rid="tbl1" ref-type="table">Table 1</xref>). Of the seven individuals who are at least 2 years old, five can walk independently. Speech is significantly impacted in all affected individuals, with most using only short (three-word) phrases even at 7&#x2013;11 years old; two individuals successfully use assistive communication devices. Three of four individuals who are school-aged require special education settings and exhibit hyperactivity. Eye abnormalities were common and included strabismus (5/7), central visual impairment (2/7), and congenital cataracts (1/7). Nearly all (6/7) individuals have microcephaly, with head size ranging from 2.1 to 5 standard deviations below the mean. One individual (individual 5) exhibited slowed head growth, with an occipital frontal circumference (OFC) that dropped from 42<sup>nd</sup> percentile to 15<sup>th</sup> percentile by age 10 years. Facial features are shown in <xref rid="fig1" ref-type="fig">Figure&#xA0;1</xref>.<table-wrap position="float" id="tbl1"><label>Table 1</label><caption><p>Summary of clinical features of individuals with <italic>de novo</italic> (p.Arg158Cys) variant in <italic>ARPC4</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Individual (gender, current age)</th><th>Variant (protein)</th><th>Inheritance</th><th>OFC (age)</th><th>Motor development</th><th>Speech</th><th>Other</th></tr></thead><tbody><tr><td rowspan="2">1a, (F, 9 years)</td><td rowspan="2">p.Arg158Cys</td><td rowspan="2"><italic>de novo</italic><xref rid="tblfn1" ref-type="table-fn">a</xref></td><td>&#x2212;3.2 SD (7&#xA0;months)</td><td rowspan="2">crawled at 10&#xA0;months; walked at 18&#xA0;months</td><td rowspan="2">expressive delays; 10 words at 2.5 years; at 4 years speech noted to be at 15-to 18-month level; 3-word phrases at 9 years</td><td rowspan="2">strabismus, accommodative esotropia; thumb-in-palm (splinted); ADHD, tantrums; facial telangiectasias</td></tr><tr><td>&#x2212;5 SD (9 years 4&#xA0;months)</td></tr><tr><td rowspan="2">1b, (M, 7 years)</td><td rowspan="2">p.Arg158Cys</td><td rowspan="2"><italic>de novo</italic><xref rid="tblfn1" ref-type="table-fn">a</xref></td><td>&#x2212;2.6 SD (7&#xA0;months)</td><td rowspan="2">sat at 1 year; walked at 22&#xA0;months</td><td rowspan="2">first words 18&#x2013;24&#xA0;months; 3-word phrases at 7 years; uses assistive communication device</td><td rowspan="2">ADHD; clasped thumbs, 5<sup>th</sup> finger camptodactyly (splinted); facial telangiectasias</td></tr><tr><td>&#x2212;3 SD (7 years 5&#xA0;months)</td></tr><tr><td>2, (F, 6 years)</td><td>p.Arg158Cys</td><td><italic>de novo</italic></td><td>&#x2212;2.8 SD (6 years 9&#xA0;months)</td><td>sat at 12&#xA0;months; walked at 14&#x2013;16&#xA0;months; pincer at 4 years</td><td>short phrases since 3 years</td><td>strabismus (surgery &#xD7;2)</td></tr><tr><td rowspan="2">3, (F, 14&#xA0;months)</td><td rowspan="2">p.Arg158Cys</td><td rowspan="2"><italic>de novo</italic></td><td>5% (14&#xA0;months)</td><td rowspan="2">walked by 22&#xA0;months; descends stairs at 26&#xA0;months; turns pages; holds sippy cup</td><td rowspan="2">no expressive language at 26&#xA0;months; uses assistive communication device</td><td rowspan="2">congenital cataracts, strabismus, CVI; thumb abduction; low RBC plasmalogens</td></tr><tr><td>&#x2212;2.5 SD (26&#xA0;months)</td></tr><tr><td rowspan="3">4, (M, 2 years)</td><td rowspan="3">p.Arg158Cys</td><td rowspan="3"><italic>de novo</italic></td><td>4% (birth)</td><td rowspan="3">sits at 20&#xA0;months, attempting to crawl; palmar grasp (20&#xA0;months); holds toys</td><td rowspan="3">babbling at 24&#xA0;months; nonverbal at 35&#xA0;months</td><td rowspan="3">CVI, myopic astigmatism; apraxia; hydronephrosis; short stature</td></tr><tr><td>&#x2212;3.8 SD (14&#xA0;months)</td></tr><tr><td>&#x2212;2.7 SD (32&#xA0;months)</td></tr><tr><td rowspan="2">5, (F, 11 years)</td><td rowspan="2">p.Arg158Cys</td><td rowspan="2"><italic>de novo</italic></td><td>42% (birth)</td><td rowspan="2">sat at 9&#xA0;months; crawled at 13&#xA0;months; walked at 17&#xA0;months</td><td rowspan="2">words by 2 years; uses phrases; articulation difficulties</td><td rowspan="2">intermittent exotropia; severe hyperactivity, impulsivity, aggression; scoliosis</td></tr><tr><td>15% (10 years 8&#xA0;months)</td></tr><tr><td rowspan="2">6, (F, 4 years)</td><td rowspan="2">p.Arg158Cys</td><td rowspan="2"><italic>de novo</italic></td><td>4% (birth)</td><td rowspan="2">moderate delays; not walking at 4 years</td><td rowspan="2">nonverbal at 4 years</td><td rowspan="2">strabismus; myelomeningocele, tethered cord; malplaced thumbs; pulmonic stenosis; L inguinal hernia; stereotypies; IQ 52</td></tr><tr><td>&#x2212;2.1 SD (16&#xA0;months)</td></tr></tbody></table><table-wrap-foot><fn><p>OFC, occipital frontal circumference; ADHD, attention deficit hyperactivity disorder; CVI, cortical visual impairment; F, female; M, male; RBC, red blood cell; SD, standard deviation.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn1"><label>a</label><p id="ntpara0020">Maternal mosaicism (0.7%).</p></fn></table-wrap-foot></table-wrap><fig id="fig1"><label>Figure&#xA0;1</label><caption><p>Facial photographs of affected individuals</p><p>(A) Individual 1a at 9 years 4&#xA0;months.</p><p>(B and C) Individual 1b at 7 years 5&#xA0;months.</p><p>(D and E) Individual 4 in infancy (D) and at 1 year (E).</p><p>(F) Individual 5.</p><p>(G&#x2013;I) Individual 6. Shared features include thin upper lip, long palpebral fissures that are slightly upslanting, and mild micrognathia in some affected individuals.</p><p>(J) Magnetic resonance imaging (MRI) for individual 4 showing nonspecific prominence of ventricles, sulci, and subarachnoid spaces diffusely and incomplete inversion of hippocampi.</p></caption><graphic xlink:href="gr1"/></fig></p>
      <p id="p0030">The ARPC2 and ARPC4 proteins form the primary site at which the ARP2/3 complex binds to the side of an existing F-actin filament. This interface is critical for the nucleation of new daughter F-actin filaments and the stability of the resulting F-actin branch network. The R158 residue in ARPC4 is one of several amino acids located at the interface between the ARP2/3 complex and F-actin and is predicted to interact with the surface of F-actin through the formation of a salt bridge.<xref rid="bib9" ref-type="bibr"><sup>9</sup></xref> The p.Arg158Cys variant replaces a positively charged arginine residue with an uncharged cystine residue, preventing salt bridge formation. As such, the p.Arg158Cys recurrent variant is predicted to have an adverse effect on the ARP2/3 complex&#x2019;s ability to bind F-actin.</p>
      <p id="p0035">Though there are no recognizable functional domains in ARPC4, and it is overall tolerant to missense variants (gnomADv2.1.1, <italic>Z</italic> = 2.21), the recurrence of the p. Arg158Cys variant in seven individuals with similar phenotypes strongly supported its implication in human disease. To verify that the recurrent ARPC4:p.Arg158Cys variant impacts protein function, we evaluated F-actin abundance in fibroblasts from affected and unaffected individuals. Primary fibroblast cultures were established from skin biopsies from the two affected siblings with the recurrent p.Arg158Cys variant (1a and 1b), as well as from skin biopsies from two unrelated, unaffected control subjects. Fibroblasts were maintained in DMEM supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin. All experiments were performed on cells whose passage number did not exceed 10. Immunostaining for F-actin was performed on 2% paraformaldehyde-fixed fibroblasts according to standard protocols using actin stain conjugated to Alexa-555 (100&#xA0;nM, Cytoskeleton) incubated for 30&#xA0;min at room temperature. DAPI (4&#x2032;,6-diamidino-2-phenylindole) was used to visualize the nuclei. Fluorescent images were captured using a Zeiss LSM 880 laser scanning microscope equipped with Airyscan technology. All immunostaining was performed in triplicate. F-actin abundance was measured as the fluorescence intensity per cell normalized to the cell area (n = 155&#x2013;193 per individual). We observed a 43% decrease in F-actin abundance in the cells from affected individuals compared to control individuals (<xref rid="fig2" ref-type="fig">Figure&#xA0;2</xref>), confirming that the p.Arg158Cys variant disrupts ARPC4 function and F-actin network formation. These results, along with the fact that there are no loss-of-function variants in <italic>ARPC4</italic> in the gnomAD database, suggest that the p.Arg158Cys variant causes a loss of ARPC4 function. We cannot rule out a dominant negative effect, though this may be less likely, as complete lack of ARPC4 is embryonic lethal in mice.<fig id="fig2"><label>Figure&#xA0;2</label><caption><p>Reduced F-actin fibers in fibroblasts from affected individuals</p><p>Representative immunofluorescent images showing a reduction in the intensity of actin staining in the fibroblasts of affected individuals (1a and 1b) compared to unaffected control individuals (Ctrl). F-actin was quantified by measuring the average cellular actin fluorescent intensity. Error bars represent SEM. The scale bar represents 20&#xA0;&#x3BC;m. The experiment was performed in triplicate with a combined n = 155&#x2013;193 per individual; representative images shown. &#x2217;&#x2217;&#x2217;&#x2217;p &lt; 0.0001 by two-tailed unpaired Student&#x2019;s t test.</p></caption><graphic xlink:href="gr2"/></fig></p>
      <p id="p0040">Primary microcephaly, which was observed in 6/7 individuals in this study, is caused by a disruption in the proliferation of the neuronal progenitor cells, which leads to the depletion of the neural progenitor pool, an overall reduction in neuron production, and ultimately a smaller-than-expected brain. Many of the genes associated with primary microcephaly encode centrosome proteins, although other pathways, such as DNA repair, have also been implicated.<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> The actin cytoskeleton is crucial to neuronal progenitor cell proliferation. It is a major component of the cleavage furrow, and chemical inhibition of actin filaments leads to cytokinesis failure and cell cycle arrest.<xref rid="bib10" ref-type="bibr"><sup>10</sup></xref> Additionally, neuronal progenitor cell differentiation begins through asymmetrical cell division, where the actin cytoskeleton coordinates the enrichment of cell fate determining proteins into one daughter cell, which escapes proliferation and enters neurogenesis.<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> Disruption of this actin-dependent process can lead to premature differentiation, depleting the pool of neuronal progenitor cells.</p>
      <p id="p0045">Apart from its role in cell division, the actin cytoskeleton is crucial for many other developmental processes in the brain. Remodeling of the actin cytoskeleton provides the mechanical force necessary for cell migration and modulation of cell shape, processes that play a critical role in neuron migration, axon guidance, and the regulation of synapse morphology.<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref> The importance of the ARP2/3 complex is most evident in the dendritic spines of excitatory neurons, where it is responsible for the production of a dense network of branched actin. Loss of the Arp2/3 complex from postnatal excitatory neurons led to the loss of plasticity of dendritic spines, a reduction in the number of spines, and behavioral abnormalities in mice.<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref> At the excitatory synapses, primarily located in the dendritic spines, the ARP2/3-derived actin cytoskeleton facilitates signaling between the postsynaptic density scaffold proteins and various cell membrane and intracellular molecules, which is crucial for synaptic plasticity.<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref> Through its central role maintaining and remodeling the actin cytoskeleton, the ARP2/3 complex influences neurodevelopment, cognitive performance, and social behavior.</p>
      <p id="p0050">Several other neurological disorders are due to pathogenic variants in genes involved in the formation and regulation of the actin cytoskeleton. <italic>FLNA</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="300017" id="intref0020">300017</ext-link>), the leading cause of X-linked periventricular heterotopia, forms crosslinks between actin filaments to stabilize the actin cytoskeleton. <italic>CAPZA2</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="601571" id="intref0025">601571</ext-link>), associated with intellectual disability and developmental delay, is a member of an F-actin capping complex and is necessary for the stabilization of F-actin filaments.<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> Biallelic, truncating variants in the F-actin nucleation factor <italic>FMN2</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="606373" id="intref0030">606373</ext-link>) cause autosomal-recessive intellectual disability.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> Disruption of <italic>SHANK3</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="606230" id="intref0035">606230</ext-link>), which interacts with the ARP2/3 complex to stabilize F-actin, causes Phelan-McDermid syndrome, characterized by hypotonia, global developmental delay, autistic behaviors, and profound language delays.<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref>
<italic>CYFIP2</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="606323" id="intref0040">606323</ext-link>), which is associated with developmental and epileptic encephalopathy, is a subunit of the WAVE-regulatory complex and promotes F-actin nucleation through activation of the ARP2/3 complex.<xref rid="bib17" ref-type="bibr"><sup>17</sup></xref> Even actin is implicated in neurological disease. Gain-of-function variants in <italic>ACTB</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="102630" id="intref0045">102630</ext-link>) or <italic>ACTG1</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="102560" id="intref0050">102560</ext-link>), which encode nearly identical actin subunits, cause a syndromic neurodevelopmental disorder characterized by developmental delay, intellectual disability, and internal organ abnormalities.<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> Since most actin regulatory proteins are broadly expressed,<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref> the enrichment of neurological abnormalities in these disorders provides further evidence that the cells in the nervous system are particularly susceptible to disruption of the actin cytoskeleton.</p>
      <p id="p0055">In summary, we report seven individuals with the same recurrent, <italic>de novo</italic> variant in <italic>ARPC4</italic> and a neurodevelopmental disorder characterized by microcephaly, mild motor delays, and significant speech impairment. Identification of additional affected individuals will provide further insight into the range of neurological features associated with <italic>ARPC4</italic> and elucidate the full mutational spectrum in <italic>ARPC4</italic> capable of causing disease.</p>
    </sec>
    <sec id="sec3">
      <title>Consortia</title>
      <p id="p0065">Italian Undiagnosed Diseases Network members: Domenica Taruscio, Marco Salvatore, Agata Polizzi, Federica Censi, Giovanna Floridia (Undiagnosed Rare Diseases Interdepartmental Unit, National Centre for Rare Diseases, Istituto Superiore di Sanit&#xE0; 00161 Rome, Italy); Giuseppe Novelli, Federica Sangiuolo (Department of Biomedicine and Prevention, Genetics Section, University of Rome Tor Vergata, Rome 00133, Italy); Erica Daina (IRCCS Mario Negri Pharmacological Research Institute, Bergamo 24020, Italy); Dario Roccatello (Nephrology and Dialysis Unit, Immunopathology and Rare Diseases Research Center, San Giovanni Bosco Hospital, Turin, Italy); Simone Baldovino, Elisa Menegatti (Department of Clinical and Biological Sciences, University of Turin, Turin 10154, Italy).</p>
    </sec>
  </body>
  <back>
    <ref-list id="cebib0010">
      <title>References</title>
      <ref id="bib1">
        <label>1</label>
        <element-citation publication-type="journal" id="sref1">
          <person-group person-group-type="author">
            <name>
              <surname>Lian</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Sheen</surname>
              <given-names>V.L.</given-names>
            </name>
          </person-group>
          <article-title>Cytoskeletal proteins in cortical development and disease: actin associated proteins in periventricular heterotopia</article-title>
          <source>Front. Cell. Neurosci.</source>
          <volume>9</volume>
          <year>2015</year>
          <fpage>99</fpage>
          <pub-id pub-id-type="pmid">25883548</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <label>2</label>
        <element-citation publication-type="journal" id="sref2">
          <person-group person-group-type="author">
            <name>
              <surname>Jayaraman</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Bae</surname>
              <given-names>B.I.</given-names>
            </name>
            <name>
              <surname>Walsh</surname>
              <given-names>C.A.</given-names>
            </name>
          </person-group>
          <article-title>The Genetics of Primary Microcephaly</article-title>
          <source>Annu. Rev. Genomics Hum. Genet.</source>
          <volume>19</volume>
          <year>2018</year>
          <fpage>177</fpage>
          <lpage>200</lpage>
          <pub-id pub-id-type="pmid">29799801</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <label>3</label>
        <element-citation publication-type="journal" id="sref3">
          <person-group person-group-type="author">
            <name>
              <surname>Pollard</surname>
              <given-names>T.D.</given-names>
            </name>
            <name>
              <surname>Borisy</surname>
              <given-names>G.G.</given-names>
            </name>
          </person-group>
          <article-title>Cellular motility driven by assembly and disassembly of actin filaments</article-title>
          <source>Cell</source>
          <volume>112</volume>
          <year>2003</year>
          <fpage>453</fpage>
          <lpage>465</lpage>
          <pub-id pub-id-type="pmid">12600310</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <label>4</label>
        <element-citation publication-type="journal" id="sref4">
          <person-group person-group-type="author">
            <name>
              <surname>Goley</surname>
              <given-names>E.D.</given-names>
            </name>
            <name>
              <surname>Welch</surname>
              <given-names>M.D.</given-names>
            </name>
          </person-group>
          <article-title>The ARP2/3 complex: an actin nucleator comes of age</article-title>
          <source>Nat. Rev. Mol. Cell Biol.</source>
          <volume>7</volume>
          <year>2006</year>
          <fpage>713</fpage>
          <lpage>726</lpage>
          <pub-id pub-id-type="pmid">16990851</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <label>5</label>
        <element-citation publication-type="journal" id="sref5">
          <person-group person-group-type="author">
            <name>
              <surname>Gournier</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Goley</surname>
              <given-names>E.D.</given-names>
            </name>
            <name>
              <surname>Niederstrasser</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Trinh</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Welch</surname>
              <given-names>M.D.</given-names>
            </name>
          </person-group>
          <article-title>Reconstitution of human Arp2/3 complex reveals critical roles of individual subunits in complex structure and activity</article-title>
          <source>Mol. Cell</source>
          <volume>8</volume>
          <year>2001</year>
          <fpage>1041</fpage>
          <lpage>1052</lpage>
          <pub-id pub-id-type="pmid">11741539</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <label>6</label>
        <element-citation publication-type="journal" id="sref6">
          <person-group person-group-type="author">
            <name>
              <surname>van der Kammen</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>J.Y.</given-names>
            </name>
            <name>
              <surname>de Rink</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Janssen</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Madonna</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Scarponi</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Albanesi</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Brugman</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Innocenti</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Knockout of the Arp2/3 complex in epidermis causes a psoriasis-like disease hallmarked by hyperactivation of transcription factor Nrf2</article-title>
          <source>Development</source>
          <volume>144</volume>
          <year>2017</year>
          <fpage>4588</fpage>
          <lpage>4603</lpage>
          <pub-id pub-id-type="pmid">29113991</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <label>7</label>
        <element-citation publication-type="journal" id="sref7">
          <person-group person-group-type="author">
            <name>
              <surname>Myers</surname>
              <given-names>C.T.</given-names>
            </name>
            <name>
              <surname>Hollingsworth</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Muir</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>Thuesmunn</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Knupp</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Lacroix</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Mehaffey</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Berkovic</surname>
              <given-names>S.F.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Parental Mosaicism in &#x201C;De Novo&#x201D; Epileptic Encephalopathies</article-title>
          <source>N.&#xA0;Engl. J. Med.</source>
          <volume>378</volume>
          <year>2018</year>
          <fpage>1646</fpage>
          <lpage>1648</lpage>
          <pub-id pub-id-type="pmid">29694806</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <label>8</label>
        <element-citation publication-type="journal" id="sref8">
          <person-group person-group-type="author">
            <name>
              <surname>Sobreira</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Schiettecatte</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Valle</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Hamosh</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>GeneMatcher: a matching tool for connecting investigators with an interest in the same gene</article-title>
          <source>Hum. Mutat.</source>
          <volume>36</volume>
          <year>2015</year>
          <fpage>928</fpage>
          <lpage>930</lpage>
          <pub-id pub-id-type="pmid">26220891</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <label>9</label>
        <element-citation publication-type="journal" id="sref9">
          <person-group person-group-type="author">
            <name>
              <surname>Goley</surname>
              <given-names>E.D.</given-names>
            </name>
            <name>
              <surname>Rammohan</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Znameroski</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Firat-Karalar</surname>
              <given-names>E.N.</given-names>
            </name>
            <name>
              <surname>Sept</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Welch</surname>
              <given-names>M.D.</given-names>
            </name>
          </person-group>
          <article-title>An actin-filament-binding interface on the Arp2/3 complex is critical for nucleation and branch stability</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>107</volume>
          <year>2010</year>
          <fpage>8159</fpage>
          <lpage>8164</lpage>
          <pub-id pub-id-type="pmid">20404198</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <label>10</label>
        <element-citation publication-type="journal" id="sref10">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Actin dysfunction activates ERK1/2 and delays entry into mitosis in mammalian cells</article-title>
          <source>Cell Cycle</source>
          <volume>6</volume>
          <year>2007</year>
          <fpage>1487</fpage>
          <lpage>1495</lpage>
          <pub-id pub-id-type="pmid">17582224</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <label>11</label>
        <element-citation publication-type="journal" id="sref11">
          <person-group person-group-type="author">
            <name>
              <surname>Knoblich</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms of asymmetric stem cell division</article-title>
          <source>Cell</source>
          <volume>132</volume>
          <year>2008</year>
          <fpage>583</fpage>
          <lpage>597</lpage>
          <pub-id pub-id-type="pmid">18295577</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <label>12</label>
        <element-citation publication-type="journal" id="sref12">
          <person-group person-group-type="author">
            <name>
              <surname>Spence</surname>
              <given-names>E.F.</given-names>
            </name>
            <name>
              <surname>Soderling</surname>
              <given-names>S.H.</given-names>
            </name>
          </person-group>
          <article-title>Actin Out: Regulation of the Synaptic Cytoskeleton</article-title>
          <source>J.&#xA0;Biol. Chem.</source>
          <volume>290</volume>
          <year>2015</year>
          <fpage>28613</fpage>
          <lpage>28622</lpage>
          <pub-id pub-id-type="pmid">26453304</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <label>13</label>
        <element-citation publication-type="journal" id="sref13">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>I.H.</given-names>
            </name>
            <name>
              <surname>Racz</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Burianek</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Weinberg</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Yasuda</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Wetsel</surname>
              <given-names>W.C.</given-names>
            </name>
            <name>
              <surname>Soderling</surname>
              <given-names>S.H.</given-names>
            </name>
          </person-group>
          <article-title>Disruption of Arp2/3 results in asymmetric structural plasticity of dendritic spines and progressive synaptic and behavioral abnormalities</article-title>
          <source>J.&#xA0;Neurosci.</source>
          <volume>33</volume>
          <year>2013</year>
          <fpage>6081</fpage>
          <lpage>6092</lpage>
          <pub-id pub-id-type="pmid">23554489</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <label>14</label>
        <element-citation publication-type="journal" id="sref14">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Mao</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>van Jaarsveld</surname>
              <given-names>R.H.</given-names>
            </name>
            <name>
              <surname>Shu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Terhal</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Jia</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Xi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Peng</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>S.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Variants in CAPZA2, a member of an F-actin capping complex, cause intellectual disability and developmental delay</article-title>
          <source>Hum. Mol. Genet.</source>
          <volume>29</volume>
          <year>2020</year>
          <fpage>1537</fpage>
          <lpage>1546</lpage>
          <pub-id pub-id-type="pmid">32338762</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <label>15</label>
        <element-citation publication-type="journal" id="sref15">
          <person-group person-group-type="author">
            <name>
              <surname>Law</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Dixon-Salazar</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Jerber</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Cai</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Abbasi</surname>
              <given-names>A.A.</given-names>
            </name>
            <name>
              <surname>Zaki</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Mittal</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Gabriel</surname>
              <given-names>S.B.</given-names>
            </name>
            <name>
              <surname>Rafiq</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>V.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Biallelic truncating mutations in FMN2, encoding the actin-regulatory protein Formin 2, cause nonsyndromic autosomal-recessive intellectual disability</article-title>
          <source>Am. J. Hum. Genet.</source>
          <volume>95</volume>
          <year>2014</year>
          <fpage>721</fpage>
          <lpage>728</lpage>
          <pub-id pub-id-type="pmid">25480035</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <label>16</label>
        <element-citation publication-type="journal" id="sref16">
          <person-group person-group-type="author">
            <name>
              <surname>Durand</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Betancur</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Boeckers</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Bockmann</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Chaste</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Fauchereau</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Nygren</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Rastam</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gillberg</surname>
              <given-names>I.C.</given-names>
            </name>
            <name>
              <surname>Anckars&#xE4;ter</surname>
              <given-names>H.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders</article-title>
          <source>Nat. Genet.</source>
          <volume>39</volume>
          <year>2007</year>
          <fpage>25</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="pmid">17173049</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <label>17</label>
        <element-citation publication-type="journal" id="sref17">
          <person-group person-group-type="author">
            <name>
              <surname>Nakashima</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Aoto</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Shiina</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Belal</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Mukaida</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kumada</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Zerem</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lerman-Sagie</surname>
              <given-names>T.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>De novo hotspot variants in CYFIP2 cause early-onset epileptic encephalopathy</article-title>
          <source>Ann. Neurol.</source>
          <volume>83</volume>
          <year>2018</year>
          <fpage>794</fpage>
          <lpage>806</lpage>
          <pub-id pub-id-type="pmid">29534297</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <label>18</label>
        <element-citation publication-type="journal" id="sref18">
          <person-group person-group-type="author">
            <name>
              <surname>Cuvertino</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Stuart</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>Chandler</surname>
              <given-names>K.E.</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Armstrong</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Bernardini</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Bhaskar</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Callewaert</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Clayton-Smith</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Davalillo</surname>
              <given-names>C.H.</given-names>
            </name>
            <etal/>
            <collab>DDD Study</collab>
          </person-group>
          <article-title>ACTB Loss-of-Function Mutations Result in a Pleiotropic Developmental Disorder</article-title>
          <source>Am. J. Hum. Genet.</source>
          <volume>101</volume>
          <year>2017</year>
          <fpage>1021</fpage>
          <lpage>1033</lpage>
          <pub-id pub-id-type="pmid">29220674</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <label>19</label>
        <element-citation publication-type="journal" id="sref19">
          <person-group person-group-type="author">
            <name>
              <surname>Consortium</surname>
              <given-names>G.T.</given-names>
            </name>
            <collab>GTEx Consortium</collab>
          </person-group>
          <article-title>The Genotype-Tissue Expression (GTEx) project</article-title>
          <source>Nat. Genet.</source>
          <volume>45</volume>
          <year>2013</year>
          <fpage>580</fpage>
          <lpage>585</lpage>
          <pub-id pub-id-type="pmid">23715323</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="appsec1">
      <title>Data availability</title>
      <p id="p0185">This study collated results of clinical exome sequence and did not generate/analyze sequence data.</p>
    </sec>
    <sec id="appsec2">
      <title>Web resources</title>
      <p id="p0085">
<list list-type="simple" id="ulist0010"><list-item id="u0010"><p id="p0090">OMIM, <ext-link ext-link-type="uri" xlink:href="https://www.omim.org" id="intref0055">https://www.omim.org</ext-link></p></list-item></list>
</p>
    </sec>
    <ack id="ack0010">
      <title>Acknowledgments</title>
      <p id="p0070">The Italian Undiagnosed Diseases Network was funded by <funding-source id="gs1">Italian Ministry of Foreign Affairs</funding-source> (grant PGR00229, 2016&#x2013;2019) and <funding-source id="gs2">Farmindustria</funding-source>.</p>
      <sec sec-type="COI-statement" id="sec4">
        <title>Declaration of interests</title>
        <p id="p0075">K.G.M., T.S.S., and I.M.W. are employees of GeneDx, Inc. All other authors declare no competing interests.</p>
      </sec>
    </ack>
  </back>
</article>
</pmc-articleset>